Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05100836 · ClinicalTrials.gov registry record
SURPASS Impella 5.5 Study
A clinical trial, sponsored by Abiomed.
- Completed
- Registry status
- 1,017
- Enrollment target
NCT05100836 is a clinical trial that has completed, run by Abiomed. The registered enrollment target is 1,017 participants.
The verdict
NCT05100836 has completed, sponsored by Abiomed.
- COMPLETED
- Registry status
- 1,017 participants
- Enrollment target
Study Summary
A multi-center, prospective \& retrospective, observational single-arm study of the clinical outcomes up to one year collected from electronic health records of patients which have undergone standard of care implantation of Impella 5.5, regardless of clinical situation or indication. All patients will be enrolled via an IRB-approved Waiver of Informed Consent and HIPAA Authorization. All patients who were supported retrospectively (prior to site IRB approval) with Impella 5.5 at the investigative site will be entered into the SURPASS registry and specified as the retrospective cohort.
Interventions
- DEVICE Impella 5.5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,017 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2025-05-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05100836
The ClinicalTrials.gov registry entry for NCT05100836 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,017 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abiomed, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Impella 5.5 is the first listed.
NCT05100836 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05100836 about?
NCT05100836 is a clinical study titled "SURPASS Impella 5.5 Study". A multi-center, prospective \& retrospective, observational single-arm study of the clinical outcomes up to one year collected from electronic health records of patients which have undergone standard of care implantation of Impella 5.5, regardless of clinical situation or indication. All patients wi...
What is the current status of trial NCT05100836?
This trial is currently completed. The enrollment target is 1,017 participants. The study started on 2020-09-21. Estimated completion is 2025-05-14.
What interventions are being tested in trial NCT05100836?
The interventions under investigation include: Impella 5.5 (DEVICE).
Who is sponsoring clinical trial NCT05100836?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.